Capsule Type Seated Hard Hyperbaric Oxygen Chamber 2.0ATA Anti-Aging Lying

Name: Capsule Type Seated Hard Hyperbaric Oxygen Chamber 2.0ATA Anti-Aging Lying
Brand: Nanjing Kingshare Biotechnology Co., Ltd.
SKU: 2112280122

Jiangsu, ChinaNanjing Kingshare Biotechnology Co., Ltd.

US$37,000.00-45,000.00

1 Set

Product profile

Customization

Available

Certification

CE, ISO13485

LCD Display

With LCD Display

Model NO.

KX-YS01

Group

Adult

OEM&ODM

Available

Application

Health Care Physical Therapy

Chamber Pressure

2.0 ATA

Certificate

CE/ISO/FCC

Oxygen Purity

95% Purity Oxygen

Material

Stainless Steel

Logo

Free

Lead Time

1 Week

Loading Port

Shenzhen

OEM

Yes

Color

Customized

Warranty

1 Years

Transport Package

Plywood and Caron Box

Specification

L2200*W1000*H1800mm

Trademark

Kingshare Alpha O2

Origin

China

Production Capacity

500sets/Month

Company profile

Standardized quality controlQuality AssuranceProduct CertificationFast Delivery

Nanjing Kingshare Biotechnology Co., Ltd.

Jiangsu, China

CertifiedBusiness Type: Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 3 Years CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.87h

AI-Powered supplier vetting

SummaryKingShare Biotech is presented as a vertically integrated biotechnology solutions provider with more than 20 years of experience and its own manufacturing facility exceeding 5,000 square meters. It reports professional R&D capability, 3D software design, broad customization services, documented design controls, and technical support covering production and after-sales service. Production information includes annual output of 10,800 hyperbaric oxygen chamber sets, inventory capability, and standardized finished-product inspection instructions. However, only one QA/QC inspector is reported, and the supplier lacks overseas warehouses, showrooms, agents, or branches. Service-capability supplier management is weakly documented, with no written assessment procedures, approved-supplier list, or corrective/preventive-action records. Financial credibility cannot be favorably assessed because the provided financial data is zero-valued and incomplete. No certifications or customer cases are explicitly provided.

Supplier typeThe supplier identifies itself as a vertically integrated biotechnology solutions provider with its own manufacturing facility and global B2B sales models. Its stated business scope includes medical-device production and sales of separation, purification, and mechanical equipment, supporting classification as a manufacturer and technical solution supplier.

After-Sales capabilityTechnology engineers are responsible for technical support during production and after-sales service, indicating an internal after-sales support function. However, the supplier reports no overseas warehouse, showroom, agent, or branch capability, so overseas service coverage appears limited.

R&D capabilityThe supplier reports professional R&D capability, 3D software design, broad product-design services, technical engineers for new-product development, and available design input/output, review, verification, and validation documentation. No SDK is available, which limits software-development integration capability but does not negate the documented product R&D capability.

Production capacityThe supplier operates its own manufacturing facility exceeding 5,000 square meters, reports annual production of 10,800 hyperbaric oxygen chamber sets, and has in-stock service capability. Finished-product inspection follows documented and uniformly applied instructions, although only one QA/QC inspector is reported.

Customization capabilityThe supplier explicitly offers customization from samples, customization from designs, full customization, minor customization, and flexible customization, supported by engineers who confirm customer requirements and design new products. The availability of design-control documentation further supports structured customization execution.